154
Participants
Start Date
May 9, 2019
Primary Completion Date
December 19, 2019
Study Completion Date
January 27, 2020
Insulin icodec
Participants will receive subcutaneous (s.c.) injections of Insulin 287 OW for 16 weeks.
Insulin glargine U100
Participants will receive s.c. injections of insulin glargine OD for 16 weeks
Novo Nordisk Investigational Site, Falkensee
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Hamburg
Novo Nordisk Investigational Site, Oldenburg I. Holst
Novo Nordisk Investigational Site, Bergamo
Novo Nordisk Investigational Site, Roswell
Novo Nordisk Investigational Site, Nashville
Novo Nordisk Investigational Site, Chattanooga
Novo Nordisk Investigational Site, Chattanooga
Novo Nordisk Investigational Site, Münster
Novo Nordisk Investigational Site, Saint Ingbert-Oberwürzbach
Novo Nordisk Investigational Site, Ludwigshafen
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Hranice
Novo Nordisk Investigational Site, Holešov
Novo Nordisk Investigational Site, Catanzaro
Novo Nordisk Investigational Site, Las Vegas
Novo Nordisk Investigational Site, Walnut Creek
Novo Nordisk Investigational Site, Renton
Novo Nordisk Investigational Site, Idaho Falls
Novo Nordisk Investigational Site, Nashua
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Edmonton
Novo Nordisk Investigational Site, Surrey
Novo Nordisk Investigational Site, Vancouver
Novo Nordisk Investigational Site, Halifax
Novo Nordisk Investigational Site, Brampton
Novo Nordisk Investigational Site, Concord
Novo Nordisk Investigational Site, Etobicoke
Novo Nordisk Investigational Site, Hamilton
Novo Nordisk Investigational Site, Markham
Novo Nordisk Investigational Site, Sarnia
Novo Nordisk Investigational Site, Broumov
Novo Nordisk Investigational Site, Trutnov
Novo Nordisk Investigational Site, Roma
Lead Sponsor
Novo Nordisk A/S
INDUSTRY